Generic Versions Of Copaxone Take Toll On Teva 3Q Results - Drug Discovery and Development
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Knowledge Center | Abbott Core Laboratory
Dimethyl fumarate and teriflunomide for multiple sclerosis in a real‐life setting: a French retrospective cohort study - Condé - 2019 - European Journal of Neurology - Wiley Online Library
US5585089A - Humanized immunoglobulins - Google Patents